--- title: "Cryoport Q3 net loss widens 56% to $10.85 million; Q3 revenue rises 14% to $50.22 million" type: "News" locale: "en" url: "https://longbridge.com/en/news/304527142.md" description: "Cryoport reported a Q3 2026 net loss of $10.85 million, widening 56% year-over-year, while revenue increased 14% to $50.22 million. Life Sciences Services revenue grew 18% to $28.56 million. The company supported 788 clinical trials and 23 approved cell and gene therapies. Cryoport raised its full-year 2026 revenue guidance to $197–$199 million." datetime: "2026-11-05T21:25:14.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/304527142.md) - [en](https://longbridge.com/en/news/304527142.md) - [zh-HK](https://longbridge.com/zh-HK/news/304527142.md) generator: "portal-rs" --- # Cryoport Q3 net loss widens 56% to $10.85 million; Q3 revenue rises 14% to $50.22 million - Cryoport’s third-quarter 2026 net loss widened 56% year-over-year to $10.85 million. \* Revenue rose 14% year-over-year to $50.22 million, including Life Sciences Services revenue of $28.56 million, up 18%. \* The business supported 788 clinical trials worldwide and 23 commercially approved cell and gene therapies at September 30, 2026. \* Full-year 2026 revenue guidance increased to a range of $197 million to $199 million. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cryoport Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611051605PR\_NEWS\_USPR\_\_\_\_\_LA90523) on November 05, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) ### Related Stocks - [CYRX.US](https://longbridge.com/en/quote/CYRX.US.md) ## Related News & Research - [CryoPort (NASDAQ:CYRX) Stock: Insider Daniel Hancock Sells 74,379 Shares](https://longbridge.com/en/news/305449778.md) - [Cryoport (CYRX) Lifts 2026 Outlook Following Revenue Update As Fair Value Stays Just Behind](https://longbridge.com/en/news/304925527.md) - [Lumentum President of Global Business Units Wupen Yuen Reports Sale of $833,200 in Common Shares](https://longbridge.com/en/news/306338831.md) - [Oracle Says OpenAI Contract Is Fully Funded, Not Dependent on Further Vendor Talks](https://longbridge.com/en/news/306327746.md) - [CYRX: Revenue grew 14%, adjusted EBITDA turned positive, and 2026 guidance rose](https://longbridge.com/en/news/304526842.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**